Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gretchen Kimmick, MD, MS
Wake Forest University Health Sciences
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southeastern Medical Oncology Center
Goldsboro, North Carolina, United States
- East Carolina University School of Medicine
Greenville, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Cancer Centers of the Carolinas
Greenville, South Carolina, United States
- Palmetto Hematology/oncology Associates
Spartanburg, South Carolina, United States
- Massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 1997
- Primary completion
- 31 May 2002
- Completion
- 31 Jul 2009
- Last update posted
- 13 Aug 2018
- Registered enrollment
- 25
- Registry id
- NCT00015886
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.